PRE-EMPTIVE GANCICLOVIR THERAPY BASED ON PCR COMPARED WITH PROPHYLAXIS FOR PREVENTION OF CMV DISEASE IN HIGH RISK LIVER TRANSPLANT RECIPIENTS. Abstract# 1130

Michael E. de Vera, Gregory A. Smallwood, Laurel Davis, Andrie Stieber, Heffron Thomas

Research output: Contribution to journalMeeting abstractpeer-review

Original languageAmerican English
Pages (from-to)S407
JournalTransplantation
Volume69
Issue numberSupplement
DOIs
StatePublished - Apr 1 2000

Disciplines

  • Surgery
  • Internal Medicine
  • Medicine and Health Sciences

Cite this